Lupin receives US FDA approval for infection drug Industry-The Economic Times — July 10, 2017 comments off Ancobon capsules had sales of $46.6 million in the US, said Lupin, citing IMS Moving Annual Turnover (MAT) data for March 2017.
Ancobon capsules had sales of $46.6 million in the US, said Lupin, citing IMS Moving Annual Turnover (MAT) data for March 2017.